The mitochondrial intramembrane rhomboid protease Parl has been implicated in diverse functions in vitro, but its physiological role in vivo remains unclear. Here we show that Parl ablation in mouse causes a necrotizing encephalomyelopathy similar to Leigh syndrome, a mitochondrial disease characterized by disrupted energy production. Mice with conditional Parl deficiency in the nervous system, but not in muscle, develop a similar phenotype as germline Parl knockouts demonstrating the vital role of Parl in neurological homeostasis. Genetic modification of two major Parl substrates, Pink1 and Pgam5, do not modify this severe neurological phenotype. Parl -/-brain mitochondria are affected by severe ultrastructural changes, defects in Complex III activity, coenzyme Q biosynthesis, and mitochondrial calcium metabolism. Parl is necessary for the stable expression of Ttc19, required for Complex III activity, and of Coq4, essential in coenzyme Q biosynthesis. Thus, Parl plays a previously overseen constitutive role in the maintenance of the respiratory chain in the nervous system, and its deficiency causes progressive mitochondrial dysfunction, structural abnormalities leading to neuronal necrosis and Leighlike syndrome.
INTRODUCTION
PARL represents the only known mitochondrial member of the rhomboid family (1) . Rhomboids are evolutionary conserved intramembrane cleaving proteases and pseudo proteases involved in a variety of functions (2) . Their broad biological significance is reflected in their pathological relevance for prevalent human diseases, including cancer and neurodegenerative diseases (2) .
The crucial role of PARL in cellular homeostasis is illustrated by the lethal multisystem phenotype of Parl deficient mice (Parl -/-), associated with muscle atrophy and increased apoptosis in thymus and spleen (3) . The faster cytochrome c release and cristae remodeling in vitro, and the increased cell death of Parl -/-mouse embryonic fibroblasts (MEFs) treated with apoptosis-inducing agents rescued by overexpressed intermembrane space targeted Opa1, led to the proposal that Parl plays a role in cristae remodeling and cytochrome c release during apoptosis. The authors suggested that decreased Opa1 processing by Parl was causative to these apoptotic phenotypes. Later studies identified Oma1 and Yme1l (4) as the proteases cleaving Opa1 and questioned Opa1 as a Parl substrate. More recently, Parl has been implicated in the processing of other substrates in cultured cells (5) (6) (7) (8) (9) (10) . Two substrates, Pink1 and Pgam5, are of particular interest as they are implicated in Parkinson's disease (11, 12) . Both accumulate in Parl -/-cells (6) (7) (8) 13 ), but it is unclear whether this accumulation is detrimental (2) . A recent elegant cell biology study proposed that PARL exerts pro-apoptotic effects via misprocessing of the mitochondrial Diablo homolog (hereafter Diablo) (10) . However, this is difficult to reconcile with the lethality of Parl -/-mice and the proposed protective function of Parl (3) . Overall, the available data have led to contradictory speculations with regard to the role of Parl in apoptosis (3, 10) , mitochondrial function (3, 14) , morphology (3, 14, 15) , mitophagy (16) (17) (18) and claims have not been further substantiated in vivo. More importantly, the cause of death of the Parl -/-mice, and therefore the physiological role of this protease has remained unresolved. To address these questions, we re-investigated Parl deficient mice. In contrast with our previous report, we find now, in addition to the described phenotypes in peripheral tissues, that Parl deficiency causes a necrotizing encephalomyelopathy closely resembling Leigh syndrome, a human mitochondrial disease caused by impaired respiratory chain defects (19) . A simi- the underlying mechanism. We show that necrosis in Parl -/-brains is preceded by progressive mitochondrial structural changes and by specific defects of the respiratory chain at the level of Complex III (CIII) and Coenzyme Q (CoQ), and is associated with alter-273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300  301  302  303  304  305  306  307  308  309  310  311  312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330  331  332  333  334  335  336  337  338  339 
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(C) H&E staining of midbrain coronal sections of 7 week-old mice of the indicated genotypes (n>3). Scale bar: 500 µm.
ations in mitochondrial calcium metabolism. Thus, Parl has an essential physiological role in the maintenance of mitochondrial structure and function, which is severely impaired when Parl is ablated, causing Leigh-like neurodegeneration. We discuss how these novel insights affect our previous interpretations of the Parl -/-phenotype in vivo.
RESULTS

Parl deficiency in the nervous system leads to Leigh syndrome
Parl -/-mice develop normally up to the age of 40 days, after which they progressively lose weight (3) . From the age of six weeks, they show rapidly progressive locomotor impairment, paresis of the lower limbs, hunchback deformity, and dyspnea (Movie S1). They die before the age of eight weeks from a multisystem phenotype with atrophy of skeletal muscle, thymus and spleen (3), without a clear explanation. Immune deficiency is unlikely the cause of death because thymus and spleen become atrophic only few days before death when mice are already severely affected. Moreover mice are bred in specific pathogen free conditions and do not develop opportunistic infections, leaving open the question of which essential vital function is compromised by Parl deficiency. These clinical signs led us to ask whether this phenotype was caused by neurological involvement. Examination of the brain and spinal cord from Parl -/-mice indeed showed a previously overlooked subcortical vacuolar encephalomyelopathy closely resembling Leigh syndrome (Fig. 1A-H) . Leigh syndrome is a lethal mitochondrial disease characterized by neurological regression and pathologically by vacuolar degeneration and necrosis of the brainstem, basal ganglia and spinal cord, reactive gliosis and vascular proliferation (20) . Vacuolization of the neuropil was first detectable in Parl -/-mice at five weeks of age, initially circumscribed in the brainstem and in the gray matter of the spinal cord, and then progressively extending anteriorly to hypothalamus, thalamus, deep cerebellar nuclei, and the cingulate cortex. Other areas of the brain, notably most of the cortex, hippocampus and the substantia nigra, were spared. Neuronal loss was detectable by loss of NeuN-positive cells (Fig. 1B) . Neurodegeneration was accompanied by extensive astrogliosis and microgliosis, indicated by Gfap (Fig. 1C) and Iba1 (Fig. 1D) immunoreactivity. Luxolfast blue, a staining used to visualize the white matter, showed comparable reaction in WT and Parl -/-mice (Fig. 1E ). Consistent with neuronal involvement, in situ hybridization shows that Parl mRNA expression was particularly abundant in neurons (Fig.  1F) . In advanced stages, vascular proliferation became evident (Fig. 1G) , and symmetrical hemorrages were frequently observed at 7 weeks of age in the most severely affected areas of the brainstem and spinal cord (Fig. 1H) . When Parl was specifically ablated in the nervous system using a Nestin-Cre driver (Parl L/L ::Nes Cre ) (Fig. 1J ) a similar lethal phenotype was observed as in the germline Parl -/-mice ( Fig. 1I) including the Leigh-type neuropathology (Fig.1K) . Apart from a 4-weeks delay in lethality and the absence of testis atrophy (Fig. 1O) , these mice developed the typical Parl -/-multisystem phenotype (3) with severe atrophy of muscle, liver, spleen ( Fig.1L-N) , and thymus ( Fig. 1P ) despite normal Parl expression in these tissues (Fig. 1J) . To further assess ectopic Cre mediated recombination in these peripheral tissues, we evaluated the presence of recombination by PCR, followed by high-resolution capillary electrophoresis (SI Appendix, Fig. S1A Cre knockout mice using Cre expression driven by the Creatine kinase promoter did not compromise survival at least up to the age of 18 months nor led to overt locomotor deficits (n=13, Fig. 1I ). Altogether, these data suggest that Parl deficiency in the nervous system is sufficient to recapitulate the lethal multisystem phenotype of germline Parl -/-mice, except the gonad atrophy.
Parl deficiency causes early neuronal mitochondrial ultrastructural abnormalities followed by neuronal necrosis
To characterize mitochondrial ultrastructure and the morphological features of cell death induced by Parl deficiency in the brain we performed electron microscopy. At 3 weeks of age, which is before the occurrence of clinical signs or histopathological lesions, Parl -/-but not WT neurons of medulla oblongata, displayed scattered swollen mitochondria with abnormal cristae and a translucent matrix ( Fig.2A) . At later time points, mitochondrial ultrastructural abnormalities became progressively more severe and diffuse in the context of progressive neuronal vacuolization, swelling and loss of integrity ( Fig. 2B-C ). This picture is indicative of necrosis, while the typical morphological signs of apoptosis 409  410  411  412  413  414  415  416  417  418  419  420  421  422  423  424  425  426  427  428  429  430  431  432  433  434  435  436  437  438  439  440  441  442  443  444  445  446  447  448  449  450  451  452  453  454  455  456  457  458  459  460  461  462  463  464  465  466  467  468  469  470  471  472  473  474  475  476   4 www.pnas.org ------Footline Author   477  478  479  480  481  482  483  484  485  486  487  488  489  490  491  492  493  494  495  496  497  498  499  500  501  502  503  504  505  506  507  508  509  510  511  512  513  514  515  516  517  518  519  520  521  522  523  524  525  526  527  528  529  530  531  532  533  534  535  536  537  538  539  540  541  542  543  544 Submission PDF Fig.S2 ). Since Parl has been linked previously to apoptosis (3, 10) we investigated further its contribution to the neurodegeneration. During apoptosis, the outer mitochondrial membrane becomes permeable, and cytochrome c is released from the mitochondrial intermembrane space to the cytosol leading to proteolytic activation of executioner caspases and Parp. We analyzed mitochondrial outer membrane permeability of brain mitochondria isolated from symptomatic Parl -/-mice by measuring the enhancement of Complex IV-driven (CIV) respiration before and after addition of exogenous cytochrome c, which is unable to reach CIV if outer membranes are intact. Exogenous cytochrome c did not significantly enhance CIV-driven respiration in both WT and
Parl
-/-brain mitochondria (Fig. 2D ), indicating intactness of outer mitochondrial membranes even in advanced stages of the disease with severe neurodegeneration. Consistently, cytochrome c was undetectable in purified brain cytosols from Parl -/-brains (Fig.  2E) , and the expression of full length Parp was similar in Parl -/-and WT brains without evidence of proteolytic activation (Fig. 2F) . Accordingly, we did not see TUNEL-positive cells in the degenerating brain areas, notably brainstem, thalamus, hypothalamus at serial time points ranging from asymptomatic to late stage of the disease (SI Appendix, Fig. S3A ). TUNEL-positivity was restricted to few scattered cells undergoing developmental apoptosis in periventricular areas not affected by Parl -/-neurodegeneration. This was not more severe in Parl -/-than in WT brains. We obtained similar results using antibodies against cleaved caspase 3 in both   545  546  547  548  549  550  551  552  553  554  555  556  557  558  559  560  561  562  563  564  565  566  567  568  569  570  571  572  573  574  575  576  577  578  579  580  581  582  583  584  585  586  587  588  589  590  591  592 and WT neurons with the pro-apoptotic drug etoposide showed similar proteolytic activation of Caspase 3 and Parp indicating that apoptosis execution is not overtly blocked in cultured neurons (Fig. 2I ). All together, these data indicate that the striking neurodegeneration induced by Parl deficiency is preceded by mitochondrial ultrastructural abnormalities that accumulate with time. The neurodegeneration is characterized by neuronal necro- 681  682  683  684  685  686  687  688  689  690  691  692  693  694  695  696  697  698  699  700  701  702  703  704  705  706  707  708  709  710  711  712  713  714  715  716  717  718  719  720  721  722  723  724  725  726  727  728  729  730  731  732  733  734  735  736  737  738  739  740  741  742  743  744  745  746  747 749  750  751  752  753  754  755  756  757  758  759  760  761  762  763  764  765  766  767  768  769  770  771  772  773  774  775  776  777  778  779  780  781  782  783  784  785  786  787  788  789  790  791  792  793  794  795  796  797  798  799  800  801  802  803  804  805  806  807  808  809  810  811  812  813  814  815  816 Submission PDF 
Parl -/-Leigh-like syndrome is not caused by misprocessing of Pink1 and Pgam5
Next we wondered to what extent the neurodegenerative phenotype of Parl -/-mice can be attributed to misprocessing of the best characterized substrates of Parl, Pink1 (16, 6, 8) , a mitochondrial kinase, and Pgam5, a mitochondrial phosphatase (9) . Both have roles in neurological diseases (11, 12) and in mitophagy (12, 21) . Pgam5 has also been linked to regulation of multiple cell death pathways including necroptosis (22) . However, the contribution of Pink1 and Pgam5 misprocessing to the Parl -/-phenotype is not known (1). Expression of Lc3, p62, and Bnip3 ( Figure S4A ), which are markers of macroautophagy, and mitochondrial protein ubiquitination ( Figure S4B ), which labels proteins of dysfunctional mitochondrial for degradation by mitophagy, were not modified in Parl -/-brains, indicating unaltered steady state levels of autophagy in Parl -/-brain. Pink1 was barely detectable in WT mitochondria, while a remarkable accumulation of Pink1 was seen in Parl -/-brain mitochondria (Fig. 3A) . Similarly, the unprocessed full-length form of Pgam5 strongly accumulated in Parl -/-mitochondria while the processed form of Pgam5 migrated slightly faster than in WT mitochondria, indicating an alternative Parl-independent cleavage. To test whether accumulation of these unprocessed forms of Pink1 (Fig.3A) . Surprisingly, the Parl -/-phenotype was unmodified by simultaneous deletion of Pink1, or Pgam5, either alone or together, and all these mouse strains invariably died at a similar age as the single Parl -/- (Fig.3B ) affected by similar Leigh-like syndrome (Fig.3C) . To test whether deficient proteolytic products of Pink1 and Pgam5 generated by Parl were essential, we also generated Pink1 -/-/Pgam5 -/-mice. Conversely, Pink1 -/-/Pgam5 -/-mice had a normal lifespan (Fig. 3B) beyond the age of two years without any overt clinical or neuropathological phenotype (Fig. 3C) indicating that misprocessing of Pink1 and Pgam5 alone or together do not explain the Parl -/-associated Leigh-like syndrome
Parl deficiency leads to severe respiratory chain defects converging on Complex III and Coenzyme Q
Leigh syndrome is caused by different genetic defects that ultimately impair mitochondrial energy production (19) . Therefore, we evaluated how brain mitochondrial function is compromised by absent Parl expression. Since Parl has been previously linked to differences in mitochondrial biogenesis (14), we asked whether mitochondrial mass is affected in Parl -/-brains. Expression of respiratory chain subunits and of the outer membraner protein Tomm20 was similar in WT and Parl -/-brains at any age (Fig. 4A) , indicating unaltered mitochondrial mass. Mitochondrial DNA abundance was also not significantly different (Fig. 4F) . Next, we measured oxygen consumption rates in neuronal mitochondria derived from permeabilized synaptosomes by high-resolution respirometry supplying consecutively substrates and specific inhibitors for CI, II, and IV as illustrated in Fig. 4B . Importantly, at three weeks of age, which is three weeks before the first clinical signs of Parl -/-mice, respiration was comparable between WT and Parl -/-brain mitochondria (SI Appendix, Fig. S5A ). However, at six weeks of age, at the onset of the symptomatic stage, both ADP stimulated respiration (OXPHOS), reflecting the maximal capacity to generate ATP, and uncoupled respiration, providing an estimate of the maximal electron transfer capacity (ET), were severely diminished in Parl -/-neuronal mitochondria (Fig. 4C ). Oxygen consumption was similarly decreased when using only CI substrates (CI OXPHOS), or CI and II substrates simultaneously in both phosphorylating and uncoupled states (CI+II OXPHOS and ET). Respiration from cytochrome c oxidase (CIV) was slightly, although significantly compromised (Fig. 4C) . To localize precisely the respiratory chain defect, we measured the maximal enzymatic activities of each Complex (CI-CIV) and of ATP synthase in brain mitochondria, as well as the coupled enzymatic activity of CII+III. This enzymatic assay explores segment CIIcoenzyme Q-CIII. We detected a severe enzymatic defect of CIII and of CII+III (Fig. 4D) , while CII and IV activities were slightly, although still significantly, decreased. Next, we wondered whether the deficient CIII activity was due to abnormal CIII assembly. Blue-native-gel electrophoresis of brain mitochondria showed effective assembly and maturation of the four respiratory chain CI-IV and of ATP synthase, as well as preserved formation of the super complex (Fig. 4E) . The terminal component of CIII, Uqcrfs1, was normally incorporated, but CIII 2 showed consistently a slightly lower electrophoretic mobility in Parl -/-compared to WT mitochondria (Fig. 4E ). An identical CIII 2 migration abnormality has been recently reported in mitochondria deficient of Ttc19 (23) and gene mutations in TTC19 cause human Leigh syndrome (24) . Next to investigate unambiguously the possibility of CoQ deficiency, we directly measured CoQ levels (CoQ 9+10 ) in brain extracts and the ratio between reduced and oxidized CoQ, a sensitive marker of the electron transfer efficiency (25) . CoQ deficiency is one of the established causes of Leigh syndrome (19) . Remarkably, total CoQ levels were severely decreased in Parl -/-brains at 7 weeks of age (Fig. 4G) . Moreover, the ratio between reduced and oxidized forms of CoQ was strongly increased (Fig. 4H) indicating a marked impairment in CoQH 2 oxidation, consistent with the impaired CIII activity. These changes were in contrast to the respiration defect, already severe at the presymptomatic age of 3 weeks (SI Appendix, Fig.S5B ) indicating that CoQ deficiency is an early effect of Parl deficiency. In conclusion, Parl is required to prevent severe alterations in the respiratory chain of brain mitochondria characterized by CIII and CoQ biosynthesis defects.
Altered calcium metabolism, membrane potential, and reactive oxygen species production in Parl -/-brain mitochondria
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Increased production of reactive oxygen species (ROS) is a possible consequence of respiratory chain defects. Therefore, we measured ROS production rates in brain mitochondria supplemented with both CI and II substrates fluorometry with the H 2 O 2 sensor Amplex Ultrared as illustrated in SI Appendix, Fig.S6A . ROS production was similar in all experimental conditions except for a slight increase only with CI substrates (SI Appendix, Fig.S6B ). Consistently, protein carbonylation, a commonly used biomarker to assess oxidative stress ex vivo, was not overtly increased in Parl -/-brain mitochondria or total homogenates compared to WT (SI Appendix, Fig.S6C-D) .
Mitochondrial calcium is an important determinant of cell death and is bi-directionally related to energy metabolism. Both excessive levels of mitochondrial calcium and reduced buffering of cytosolic calcium can be detrimental (26) . Therefore, we measured the maximal calcium retention capacity in purified brain mitochondria progressively loaded with calcium (Fig 5A, left) . Parl -/-brain mitochondria showed a severely reduced calcium capacity (Fig 5A, right) . To investigate whether this defect could be explained by mitochondrial depolarization, we measured the mitochondrial potential (Δψ) in brain mitochondria supplied with CI and CII substrates in the absence and in the presence of ADP (Fig 5B) . In this experiment, Δψ is inversely related to the fluorescence of safranin which is quenched in the mitochondrial matrix of polarized mitochondria. As expected, the addition of ADP consistently led to increased fluorescence, corresponding to a drop in Δψ which reflects the use of the proton gradient to drive ATP synthesis, and the mitochondrial uncoupler CCCP led to a further increase. Δψ in Parl -/-brain mitochondria was diminished only in presence of ADP (in phosphorylating conditions), by using both CI and II substrates (Fig. 5C-D, right) , while the maximal Δψ measured in the absence of ADP was unaltered (Fig. 5C-D, left) . Therefore, the decreased mitochondrial calcium uptake, which is evaluated in the leak state in the absence of ADP, is not simply explained by mitochondrial depolarization. In conclusion, Parl deficiency leads to severe alterations of mitochondrial calcium metabolism and to modest changes in oxidative stress in the brain.
Mitochondrial proteome changes induced by Parl deficieny in the brain
We wondered what mitochondrial protein changes underlie the observed CIII and CoQ defects in Parl -/-brains. We performed a mass spectrometry-based proteome analysis of brain mitochondria purified from WT and Parl -/-mice, leading to the quantification of 781 out of 1085 proteins annotated in the mouse mitochondrial proteome in Swissprot (Table S1 ). The volcano plot showed that despite the dramatic phenotype, surprisingly few mitochondrial proteins were differentially expressed (Fig.  6A) , indicating selective effects of Parl on the mitochondrial proteome. Among these, we found a striking downregulation of the CIII regulating protein Ttc19 (23, 27) and of several proteins required for CoQ biosynthesis (Coq3, Coq4, Coq5). We also noticed the significant decrease of the sulfide-CoQ oxidoreductase, which has been recently reported to decrease in human primary CoQ defects (28) . Ghitm, a multipass inner membrane protein not previously linked to Parl, in contrast, decreased. Like Pink1 and Pgam5, also Diablo (10) increased in Parl deficient brain mitochondria (Fig. 6A) . Next, we validated these findings by western blot in brain mitochondria from WT, Parl -/-, and Parl L/L ::Nes Cre (Fig. 6B ). Since our proteomic approach identifies substrates by expression changes, we decided to include in the validation also the previously reported Parl substrates Htra2 (5), Opa1 (3), Stard7, and Clpb (10), which were not significantly different in our mass spectrometry analysis despite being covered (Fig. 6A) . Western blots confirmed the virtual disappearance of Ttc19, a marked reduction of the CoQ proteins (Coq3,Coq4,Coq5), Sqrdl, and Ghitm, and altered cleavage of Ttc19, Pgam5, Diablo, Stard7, and Clpb. The expression and processing of Htra2 and Opa1 were not impaired (Fig. 6B) . To correlate these protein changes with the clinical phenotype, we checked their expression in brain tissue over time, at the age of 1, 3, and 5 weeks, when Parl -/-mice are still asymptomatic, and at 7 weeks, when the mice are severely affected by neurological deficits (Fig. 6C, SI Appendix Fig. S7 ).
To further investigate the molecular basis of the CIII and CoQ deficiency we included in this time course an extensive panel of proteins required for CoQ biosynthesis (Fig 6C and SI  Appendix Fig. S8 ). The virtual disappearance of mature Ttc19 in Parl -/-brains at all ages indicates that Parl is required for Ttc19 maturation and expression. Coq4 was also reduced in Parl -/-brains already at 1 week of age (Fig. 6C and SI Appendix Fig.  S8 ), followed by decreased Coq3, Coq5, Coq6, Coq7, Coq9 and of Sqrdl at later time points. Other proteins already affected at the age of one week are Ghitm and Stard7 in addition to Pink1 and Pgam5, while Diablo accumulated only in late symptomatic stages (SI Appendix Fig. S7) . Expression of Clpb, Htra2, and Opa1 was largely unaffected by Parl expression at all ages, except for a tendency for increased expression of the short Opa1 isoform at 7 weeks of age (SI Appendix Fig. S7) .
To explore to what extent the catalytic function of Parl is involved in these protein changes, we checked the expression of these proteins in stable Parl -/-MEFs expressing Parl WT or catalytic inactive Parl S275A (SI Appendix, Fig. S9 ). We observed no altered mobility of Coq4, Coq5, Sqrdl in Parl -/-cultured MEFs, suggesting that they likely are not direct Parl substrates. In contrast, the processing of Ttc19, Pink1, Pgam5, Stard7, Diablo, and Clpb was clearly modified by expression of catalytically active Parl, but not by mutant Parl S275A , confirming that Parl proteolytic activity is required for the maturation of these proteins and that they are all likely genuine Parl substrates (10) . In contrast, we could again not confirm differences in Htra2 and Opa1 processing in Parl -/-MEFs suggesting that both are not Parl substrates in contrast to previous reports (3, 5) .
Effects of Parl deficiency on Ttc19 and Coq4 in liver and muscle
To investigate to what extent Parl deficiency also affects expression of Ttc19 and Coq4 in other organs than the brain, we blotted extracts of liver and skeletal muscle from Parl -/-, Parl L/L ::Nes Cre and WT mice (SI Appendix, Fig. S10 ). As in the nervous system, Ttc19 expression was almost absent in both liver and skeletal muscle tissue of. Parl -/-mice only. Coq4 was significantly diminished in both tissues, although to a lesser extent in Parl -/-muscle compared to brain and liver. Next, we checked CoQ concentrations and red/ox ratio as well as CIII activity in muscle and found altered CIII activity and CoQ red/ox ratio in. Parl -/-muscles but normal CoQ concentration. These data indicate that Parl is required for the expression of Ttc19 and Coq4 in different organs in vivo, although Parl deficiency in muscle compromises only CIII activity but not CoQ concentration.
Ttc19 deficiency causes CIII defects and altered CoQ red/ox but not altered CoQ biosynthesis
To dissect the relationship between the Ttc19 deficiency and the observed CoQ defects we generated Ttc19 -/-mice ( Fig. 7A-B ). These mice (20 out of 20) have not shown any reduced survival although they display a slight reduction in locomotor activity at one year of age. Neuropathological analysis of the brainstem of Ttc19 -/-mice at the age of seven weeks did not demonstrate lesions(SI Appendix, Fig. S11 ), at difference with Parl -/-mice. Blue-native-gel electrophoresis of Ttc19 -/-brain mitochondria showed a similar upward mobility shift of CIII 2 as seen with Parl -/-mitochondria (Fig. 7C ). Coq4 expression (Fig. 7B ) and CoQ concentration (Fig. 7D) were normal but the CoQ red/ox ratio was highly increased in Ttc19 -/- (Fig. 7E) -/-, indicating that in both models the nervous system involvement drives the disease. This observation demonstrates that the Leigh syndrome is the elusive cause of the multisystem lethal phenotype previously decribed in Parl -/-mice (3). Interestingly, severe neurological alterations have also been observed in flies carrying mutations in rhomboid-7 (31), the fly orthologue of Parl. Therefore, specific deletion of Parl in the nervous system also causes severe atrophy of skeletal muscle, thymus, and spleen as in germline Parl -/-mice (6), although with a delay of about one month. Nonspecific Cre recombinase activity driven by Nestin was very limited or undetectable in these tissues and Parl protein expression unaffected, therefore very unlikely contributing to these Parl L/L ::Nes Cre phenotypes. Moreover, the lack of overt muscle atrophy and of lethality in mice with specific deletion of Parl in muscle, as opposed to the nervous system, indicates that the severe muscle atrophy is mainly a consequence of the neurodegeneration. Brain specific deletion of the mitochondrial protease Htra2 affects thymus and spleen in a similar way as brain specific Parl deficiency (32) . Such immunological phenotypes can be caused by a variety of general stress conditions that trigger increased secretion of corticosteroids and other stress hormones which induce apoptosis in these tissues (33) Since the original description of Parl -/-mice (3), many studies have focused on possible links between Parl and apoptosis in vitro with controversial results (3, 5, 10) . Here we were unable to confirm a role of Parl in apoptosis in vivo (3), instead we observe a severe necrotic neuronal phenotype. We speculate that the necrotic encephalopathy may represent a tissue specific consequence of the severe structural and functional damage that progressively accumulate in Parl -/-neuronal mitochondria, rather than the result of a direct gatekeeping activity of Parl in regulated necrosis machineries. Although we were not able to define in further detail whether necrosis is regulated in Parl -/-brains, the neuropathological phenotype is consistent with the definition of Leigh syndrome as a necrotizing encephalomyelopathy.
Surprisingly, despite the striking neuropathology, the absence of Parl affects only a very circumscribed proportion of the brain mitochondrial proteome, which overlaps with recent proteomic data obtained in HEK293 cells (10) . One limitation of our proteomic approach is that it only evaluated protein expression but not post-translational modifications and in particular cleavage sites were not analysed. At odd with previous observations (3, 5) and consistent with following reports (10, 36) , the data presented here do not support Opa1 and Htra2 as substrates of Parl. Conversely, we find several proteins differentially regulated by Parl deficiency and several of them play important roles in neurological diseases. We tested explicitly whether Pink1 and Pgam5, two substrates of Parl involved in Parkinson's disease (11, 12) and mitophagy (12, 21) Here we show that Parl plays an essential role in the respiratory chain independently from effects on mitochondrial mass (14) by regulating proteins implicated in CIII and CoQ biogenesis. Parl is required for the expression of Ttc19 (Fig. 6B-C) and impaired proteolytic maturation of Ttc19 by Parl likely leads to its degradation by alternative mitochondrial proteases. A recent study reported that Parl is required for Ttc19 cleavage in vitro (10) but the functional consequences were not investigated. Ttc19 is involved in the turnover of the iron-sulfur protein Uqcrfs1 (23), a structural subunit of CIII essential for the catalytic activity that ensures CoQ oxidation. Here we show that impaired proteolytic maturation and expression of Ttc19 in Parl -/-tissues results in altered CIII structure and catalytic activity as in Ttc19 -/-mitochondria. The defective CIII activity is reflected by the increased fraction of reduced vs oxidized CoQ. When CIII activity is normal, CoQ red/ox ratio is low, while it is high when CIII is dysfunctional, in both Parl -/-and Ttc19 -/-mice. In addition, and independently from Ttc19, Parl modulates the expression of Coq4, a protein required for the biosynthesis of CoQ (37) . Intriguingly, the severe CoQ deficiency that we found in Parl -/-brains is followed by a secondary reduction in the expression of Sqrdl, as also recently observed in primary CoQ defects (28) . CoQ is a highly hydrophobic molecule functioning as an electron carrier from several metabolic pathways to CIII and as membrane antioxidant (38, 39 (40) . An alternative hypothesis is that Parl regulates CoQ biosynthesis indirectly by generating an early stress response that precedes the respiration defects. Recent observations show that the CoQ pathway is sensitive to different mechanisms affecting mitochondrial DNA gene expression in mouse heart tissue (41). However, in these models Parl expression was upregulated, while Coq4 was unmodified or increased, in contrast with what we observe in Parl -/-mice. Thus, the effects caused by Parl deficiency are clearly different from those reported in that study.
The Ttc19 -/-mice data indicate that the CoQ deficiency is independent from the CIII defect and therefore Parl plays an essential role in the maintenance of the respiratory chain by two distinct mechanisms. Interestingly, human mutations in TTC19 (24) , and in genes that induce CoQ deficiency (19) are independent causes of Leigh syndrome. In addition, COQ4 haploinsufficiency cause neurodegeneration in human (37) . However, deletion of Ttc19   1089  1090  1091  1092  1093  1094  1095  1096  1097  1098  1099  1100  1101  1102  1103  1104  1105  1106  1107  1108  1109  1110  1111  1112  1113  1114  1115  1116  1117  1118  1119  1120  1121  1122  1123  1124  1125  1126  1127  1128  1129  1130  1131  1132  1133  1134  1135  1136  1137  1138  1139  1140  1141  1142  1143  1144  1145  1146  1147  1148  1149  1150  1151  1152  1153  1154  1155 1157  1158  1159  1160  1161  1162  1163  1164  1165  1166  1167  1168  1169  1170  1171  1172  1173  1174  1175  1176  1177  1178  1179  1180  1181  1182  1183  1184  1185  1186  1187  1188  1189  1190  1191  1192  1193  1194  1195  1196  1197  1198  1199  1200  1201  1202  1203  1204  1205  1206  1207  1208  1209  1210  1211  1212  1213  1214  1215  1216  1217  1218  1219  1220  1221  1222 Submission PDF in mouse causes only mild neurodegeneration at advanced ages (23) , and accordingly we did not observe the massive brainstem encephalopathy in Ttc19 -/-of Parl -/-mice at comparable age (SI Appendix Fig. S11 ). One hypothesis is that the respiratory chain dysfunction determined by the combination of the CIII and CoQ defects drive the Parl -/-Leigh-like encephalopathy. This might be a possible explanation for the apparent resistance of the skeletal muscle to Parl ablation, since in this tissue decreased Coq4 is not associated with a significant drop in CoQ concentration, as in the nervous system. However, we cannot exclude that other mitochondrial functional and structural defects caused by Parl deficiency could also contribute to the pathogenesis of the neurodegeneration. We didn't find a major impact of Parl deficiency in oxidative stress in the brain but we found that Parl deficiency has severe consequences on mitochondrial calcium metabolism. Mitochondrial calcium is a critical determinant of cell death including necrosis and is particularly important in neurodegenerative disorders including Parkinson's, amyotrophic lateral sclerosis, Huntington disease (26) , and hereditary neurodegenerative diseases caused by mutations in another mitochondrial protease, AFG3L2 (42) . Moreover, mitochondrial function is bidirectionally related to mitochondrial structure, and we found that Parl -/-brain mitochondria progressive accumulate morphological abnormalities implying that Parl plays a role, whether direct or indirect, in mitochondrial ultrastructure. It is thus plausible that the drastic neurodegeneration that we report in Parl -/-mice is due to a combination of mitochondrial functional and structural defects that progressively accumulate culminating in neuronal necrosis.
Our work indicates that Parl has a constitutive physiological role in keeping mitochondrial function and structural integrity in check, with crucial consequences for the nervous system.
MATERIALS AND METHODS
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